Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy	Lethargy, Neurobehavioral Manifestations, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy	Recruiting	Phase 1 / Phase 2	2026-09-03		NCT07461220

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Integrative Research Laboratories AB	1
Otsuka Pharmaceutical Development & Commercialization, Inc.	26

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Centrum Medyczne NEUROMED	Bydgoszcz	Poland	2
Centrum Medyczne Neuroprotect	Warsaw	Poland	2
EuroMedis Sp. z o.o.	Szczecin	Poland	1
First University Multiprofile Hospital for Active Treatment MHAT - Neurology Clinic	Sofia	Bulgaria	1
Hospital de la Santa Creu i Sant Pau, Unidad de trastornos del movimiento	Barcelona	Spain	1
Hospital General Universitario de Elche	Elche	Spain	10
Hospital Universitario Ramon y Cajal	Madrid	Spain	25
Medical Center "Galileo" OOD	Pleven	Bulgaria	1
Medical Center Academica	Pleven	Bulgaria	1
Neuro-Care sp. z o.o. sp. Komandytowa	Katowice	Poland	3
NeuroKlinika Prof. Andrzej Bogucki	Lodz	Poland	1
Neurologie Berlin	Berlin	Germany	1
Universitaetsklinikum Carl Gustav Carus	Dresden	Germany	1
University Multiprofile Hospital for Active Treatment "Alexandrovska" EAD, Clinic of Neurological Diseases	Sofia	Bulgaria	1